{"gao_id": "GAO-18-83", "published": "2017-12-18T12:00:00Z", "released": "2018-01-17T07:00:00Z", "summary": "In 2015, Medicare spent about $26 billion on Part B drugs, which are typically administered under a doctor\u2019s supervision. We looked at the 84 most expensive Part B drugs and found that for about a quarter of them, Medicare represented 50% or more of their market. By law, the amount Medicare pays for a Part B drug is generally based on the drug\u2019s market price...", "title": "Medicare Part B: Medicare Represented at Least Half of the Market for 22 of the 84 Most Expensive Drugs in 2015", "topics": ["Drug prices", "Prescription drugs", "Biologics", "Market share", "Health Care", "Medicare", "Federal spending", "Medicare payments", "Fee-for-service", "Drugs", "Average sales price"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-18-83", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-18-83-highlights.pdf"}, {"title": "Full Report (37 pages)", "url": "https://www.gao.gov/assets/gao-18-83.pdf"}, {"title": "Accessible PDF (38 pages)", "url": "https://www.gao.gov/assets/690/689275.pdf"}]}